PCA3 can bind PRUNE2 pre-mRNA to form a PRUNE2/PCA3 dsRNA structure, which undergoes adenosine ADAR-dependent A-to-I RNA editing, leading to decreased expression of PRUNE2 and increased tumor cell proliferation [71]. The gene discussed is PRUNE2; the disease is neoplasm.